USC.edu
Are you a Patient?

Mark Krailo, PhD

Professor of Research Population and Public Health Sciences

Image of Mark Krailo, PhD
Is this your profile? Click to edit
Phone +1 323 442 8233
Email mkrailo@childrensoncologygroup.org
CTSI Profile

Awards

  • Ford Scholarship, 2000
  • National Research Council Postgraduate Scholarship, 2000
  • Ontario Graduate Scholarship, 2000
  • University of Windsor Entrance Award, 2000
  • Ontario Scholarship, 2000
  • Board of Governor’s Award, University of Windsor, 2000

Publications

  • Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children’s Oncology Group Study Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae035. . View in PubMed
  • Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children’s Oncology Group J Pediatr Surg. 2023 Dec; 58(12):2399-2404. . View in PubMed
  • Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcome Pharm Stat. 2023 Nov-Dec; 22(6):1031-1045. . View in PubMed
  • Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium Pediatr Blood Cancer. 2023 Aug; 70(8):e30426. . View in PubMed
  • Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children’s Oncology Group study ACCL0431 Pediatr Blood Cancer. 2023 Jul 07; e30550. . View in PubMed
  • Consensus classification of pediatric hepatocellular tumors: A report from the Children’s Hepatic tumors International Collaboration (CHIC) Pediatr Blood Cancer. 2023 Jun 29; e30505. . View in PubMed
  • Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children’s Hepatic Tumors International Collaboration (CHIC) Cancers (Basel). 2023 Jan 11; 15(2). . View in PubMed
  • Children’s Oncology Group’s 2023 blueprint for research: Bone tumors Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30583. . View in PubMed
  • Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children’s Oncology Group AHEP0731 Study Committee Pediatr Blood Cancer. 2023 07; 70(7):e30365. . View in PubMed
  • Special considerations in the design and implementation of pediatric otoprotection trials J Cancer Surviv. 2023 02; 17(1):4-16. . View in PubMed
  • Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children’s Oncology Group J Clin Oncol. 2023 06 20; 41(18):3374-3383. . View in PubMed
  • Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children’s Oncology Group Int J Radiat Oncol Biol Phys. 2023 02 01; 115(2):337-346. . View in PubMed
  • Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children’s Oncology Group Study AEWS0031 J Clin Oncol. 2023 10 20; 41(30):4724-4728. . View in PubMed
  • Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence Nat Commun. 2023 05 06; 14(1):2636. . View in PubMed
  • Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children’s Oncology Group J Clin Oncol. 2023 04 10; 41(11):2098-2107. . View in PubMed
  • Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group J Clin Oncol. 2023 05 01; 41(13):2382-2393. . View in PubMed
  • Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group Br J Cancer. 2022 Dec; 127(12):2220-2226. . View in PubMed
  • Erratum to ‘Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma’ [Eur J Cancer 170 (2022) 209-235] Eur J Cancer. 2022 Dec; 177:208-209. . View in PubMed
  • Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children’s Oncology Group Trial, AHEP0731 J Pediatr Surg. 2022 Oct; 57(10):251-256. . View in PubMed
  • Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children’s Oncology Group Eur J Cancer. 2022 Sep; 172:264-275. . View in PubMed
  • Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children’s oncology group Gynecol Oncol. 2022 09; 166(3):476-480. . View in PubMed
  • Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children’s Oncology Group J Pediatr Urol. 2022 08; 18(4):505-511. . View in PubMed
  • Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children’s oncology group J Pediatr Urol. 2022 08; 18(4):513-514. . View in PubMed
  • Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma Eur J Cancer. 2022 07; 170:209-235. . View in PubMed
  • Predicted leukocyte telomere length and risk of germ cell tumours Br J Cancer. 2022 07; 127(2):301-312. . View in PubMed
  • Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431 Lancet Oncol. 2022 05; 23(5):570-572. . View in PubMed
  • Explicit underdose control based on toxicity: Four points to consider Stat Med. 2022 11 30; 41(27):5491-5493. . View in PubMed
  • Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children’s Oncology Group (COG) AHEP0731 Study Committee J Clin Oncol. 2022 02 10; 40(5):459-467. . View in PubMed
  • Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children’s Oncology Group study Cancer. 2022 03 01; 128(5):1057-1065. . View in PubMed
  • Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children’s Oncology Group Trial (ARET0321) J Clin Oncol. 2022 11 20; 40(33):3839-3847. . View in PubMed
  • Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report Neuro Oncol. 2022 04 01; 24(4):655-664. . View in PubMed
  • Reply to J-G. Wang et al. J Clin Oncol. 2022 05 01; 40(13):1507-1508. . View in PubMed
  • Imaging Appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign from Malignant Histology J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):383-386. . View in PubMed
  • Current surgical management of children with osteosarcoma and pulmonary metastatic disease: A survey of the American Pediatric Surgical Association J Pediatr Surg. 2021 Feb; 56(2):282-285. . View in PubMed
  • Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2021 12; 68(12):e29333. . View in PubMed
  • A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis Clin Genitourin Cancer. 2021 12; 19(6):469-479. . View in PubMed
  • The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research Lancet Oncol. 2021 08; 22(8):e369-e376. . View in PubMed
  • Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial Pediatr Blood Cancer. 2021 08; 68(8):e29031. . View in PubMed
  • Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children’s Oncology Group ARAR0332 Protocol J Clin Oncol. 2021 08 01; 39(22):2463-2473. . View in PubMed
  • Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium Cancer. 2021 01 15; 127(2):193-202. . View in PubMed
  • Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma Arch Pathol Lab Med. 2021 12 01; 145(12):1564-1568. . View in PubMed
  • Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell Tumors Methods Mol Biol. 2021; 2195:263-275. . View in PubMed
  • Reply to J-G. Wang et al. J Clin Oncol. 2021 09 20; 39(27):3088-3089. . View in PubMed
  • Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children’s Oncology Group Report J Clin Oncol. 2021 12 20; 39(36):4029-4038. . View in PubMed
  • Information fraction estimation based on the number of events within the standard treatment regimen Biom J. 2020 Dec; 62(8):1960-1972. . View in PubMed
  • Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children’s oncology group AHEP 0731 liver tumor committee J Pediatr Surg. 2020 Apr; 55(4):655-659. . View in PubMed
  • A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children’s Oncology Group study (ARET 0231) Pediatr Blood Cancer. 2020 09; 67(9):e28502. . View in PubMed
  • The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database Pediatr Blood Cancer. 2020 08; 67(8):e28350. . View in PubMed
  • Development of a Data Model and Data Commons for Germ Cell Tumors JCO Clin Cancer Inform. 2020 06; 4:555-566. . View in PubMed
  • Reply to SA. Upadhyaya. J Clin Oncol. 2020 10 01; 38(28):3353-3354. . View in PubMed
  • Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children’s Oncology Group Trial ACNS0333 J Clin Oncol. 2020 04 10; 38(11):1175-1185. . View in PubMed
  • Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy JMIR Res Protoc. 2019 Sep 26; 8(8):e14406. . View in PubMed
  • Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Br J Cancer. 2019 Apr; 120(8):869. . View in PubMed
  • Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial Clin Trials. 2019 12; 16(6):599-609. . View in PubMed
  • Rejoinder Clin Trials. 2019 12; 16(6):613-615. . View in PubMed
  • Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method Pharm Stat. 2019 11; 18(6):659-670. . View in PubMed
  • Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children’s Oncology Group Eur J Cancer. 2019 11; 121:177-183. . View in PubMed
  • Results from the UK Children’s Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII) Eur J Cancer. 2019 09; 118:49-57. . View in PubMed
  • Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial Lancet Oncol. 2019 05; 20(5):719-727. . View in PubMed
  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Eur J Cancer. 2019 03; 109:36-50. . View in PubMed
  • A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2019 02; 66(2):e27524. . View in PubMed
  • Factors influencing survival after recurrence in osteosarcoma: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2019 01; 66(1):e27444. . View in PubMed
  • Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group J Clin Oncol. 2019 02 10; 37(5):396-402. . View in PubMed
  • Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group Cardiooncology. 2019; 5:15. . View in PubMed
  • Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study J Clin Oncol. 2019 12 10; 37(35):3369-3376. . View in PubMed
  • High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008 J Clin Oncol. 2019 12 01; 37(34):3192-3202. . View in PubMed
  • Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study J Clin Oncol. 2019 11 01; 37(31):2883-2891. . View in PubMed
  • A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children’s Oncology Group Phase I and Pilot Consortium (ADVL0921) Clin Cancer Res. 2019 06 01; 25(11):3229-3238. . View in PubMed
  • a-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium Cancer. 2019 10 15; 125(20):3649-3656. . View in PubMed
  • Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials Cancer Med. 2018 Jul; 7(7):2951-2959. . View in PubMed
  • Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children’s Oncology Group Br J Cancer. 2018 10; 119(7):864-872. . View in PubMed
  • Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Br J Cancer. 2018 08; 119(5):615-621. . View in PubMed
  • Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children’s Oncology Group AGCT0521 study Pediatr Blood Cancer. 2018 08; 65(8):e27111. . View in PubMed
  • Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? Gynecol Oncol. 2018 08; 150(2):253-260.. View in PubMed
  • Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium Eur J Cancer. 2018 07; 98:30-37. . View in PubMed
  • Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children’s Oncology Group AGCT 0132 study Pediatr Blood Cancer. 2018 04; 65(4). . View in PubMed
  • Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors Oncologist. 2018 02; 23(2):272. . View in PubMed
  • Family history of cancer in children and adolescents with germ cell tumours: a report from the Children’s Oncology Group Br J Cancer. 2018 01; 118(1):121-126. . View in PubMed
  • Ovarian Yolk Sac Tumors; Does Age Matter? Int J Gynecol Cancer. 2018 01; 28(1):77-84.. View in PubMed
  • Klinefelter syndrome in males with germ cell tumors: A report from the Children’s Oncology Group Cancer. 2018 10 01; 124(19):3900-3908. . View in PubMed
  • The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma Pediatr Blood Cancer. 2017 Dec; 64(12). . View in PubMed
  • Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children’s Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children’s Oncology Group J Clin Oncol. 2017 Oct 20; 35(30):3465-3473. . View in PubMed
  • Clinical trial enrollment of adolescents and young adults with sarcoma Cancer. 2017 Sep 15; 123(18):3434-3440. . View in PubMed
  • Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children’s Oncology Group Pediatr Blood Cancer. 2017 Jul; 64(7). . View in PubMed
  • Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children’s Oncology Group AHEP0731 study committee Cancer. 2017 Jun 15; 123(12):2360-2367. . View in PubMed
  • Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group J Clin Oncol. 2017 Apr 10; 35(11):1203-1210. . View in PubMed
  • Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group J Expo Sci Environ Epidemiol. 2017 07; 27(4):359-364. . View in PubMed
  • Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children’s oncology group Genes Chromosomes Cancer. 2017 07; 56(7):548-558. . View in PubMed
  • Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration Lancet Oncol. 2017 01; 18(1):122-131. . View in PubMed
  • Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial Lancet Oncol. 2017 01; 18(1):63-74. . View in PubMed
  • Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation Br J Cancer. 2017 01 03; 116(1):21-27. . View in PubMed
  • Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children’s Oncology Group Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1286-1294. . View in PubMed
  • A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG Cancer. 2017 Jan 01; 123(1):144-154. . View in PubMed
  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Lancet Oncol. 2016 Oct; 17(10):1396-1408. . View in PubMed
  • Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children’s Oncology Group J Surg Oncol. 2016 Mar; 113(4):351-4. . View in PubMed
  • Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children’s Oncology Group Pediatr Blood Cancer. 2016 Mar; 63(3):493-8. . View in PubMed
  • Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children’s Oncology Group Pediatr Blood Cancer. 2016 Feb; 63(2):370-1. . View in PubMed
  • Cancer. 2016 Jan 15; 122(2):230-7. . View in PubMed
  • Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2016 10; 63(10):1771-9. . View in PubMed
  • Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children’s Oncology Group Bone Tumor Committee Pediatr Blood Cancer. 2016 10; 63(10):1737-43. . View in PubMed
  • Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children’s Oncology Group Ann Surg Oncol. 2016 10; 23(11):3541-3547. . View in PubMed
  • Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children’s Oncology Group ACNS0423 study Neuro Oncol. 2016 10; 18(10):1442-50. . View in PubMed
  • Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children’s Oncology Group Study Ophthalmology. 2016 08; 123(8):1817-1823. . View in PubMed
  • Can Big Data Shed Light on the Origins of Pediatric Cancer? Pediatrics. 2016 06; 137(6).. View in PubMed
  • The Children’s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model Eur J Cancer. 2016 Jan; 52:92-101. . View in PubMed
  • Identification of Discrete Prognostic Groups in Ewing Sarcoma Pediatr Blood Cancer. 2016 Jan; 63(1):47-53. . View in PubMed
  • Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children’s Oncology Group Clin Cancer Res. 2016 07 15; 22(14):3643-50. . View in PubMed
  • Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children’s Cancer Group, Pediatric Oncology Group, and Children’s Oncology Group: Learning From the Past to Move Forward J Clin Oncol. 2016 09 01; 34(25):3031-8. . View in PubMed
  • p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma Cancer Res. 2016 07 01; 76(13):4002-11. . View in PubMed
  • Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children’s Oncology Group Pediatr Blood Cancer. 2016 Jan; 63(1):54-61. . View in PubMed
  • Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration J Clin Oncol. 2015 Sep 20; 33(27):3018-28. . View in PubMed
  • Rare Tumors in Children: Progress Through Collaboration J Clin Oncol. 2015 Sep 20; 33(27):3047-54. . View in PubMed
  • Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2015 Sep; 62(9):1562-6. . View in PubMed
  • Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group J Immunother. 2015 Sep; 38(7):299-305. . View in PubMed
  • Impact of central surgical review in a study of malignant germ cell tumors J Pediatr Surg. 2015 Sep; 50(9):1502-5. . View in PubMed
  • A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children’s Oncology Group study† Neuro Oncol. 2015 Aug; 17(8):1132-8. . View in PubMed
  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial J Clin Oncol. 2015 Jul 10; 33(20):2279-87. . View in PubMed
  • Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children’s Oncology Group J Pediatr Surg. 2015 Jun; 50(6):1000-3. . View in PubMed
  • Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2015 May; 62(5):759-65. . View in PubMed
  • Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children’s Oncology Group J Pathol Clin Res. 2015 Apr; 1(2):83-94. . View in PubMed
  • Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2015 Mar; 62(3):440-4. . View in PubMed
  • A summary of the osteosarcoma banking efforts: a report from the Children’s Oncology Group and the QuadW Foundation Pediatr Blood Cancer. 2015 Mar; 62(3):450-5. . View in PubMed
  • Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma–associations with tumor phenotype and survival Cancer. 2015 Mar 01; 121(5):697-707. . View in PubMed
  • EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment Ann Oncol. 2015 Feb; 26(2):407-14. . View in PubMed
  • Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children’s Oncology Group Cancer. 2015 Feb 01; 121(3):467-75. . View in PubMed
  • Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States J Clin Oncol. 2015 Jan 10; 33(2):195-201. . View in PubMed
  • Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status Epigenetics. 2015; 10(1):31-9. . View in PubMed
  • Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children’s Oncology Group Report Sarcoma. 2015; 2015:927123. . View in PubMed
  • Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2014 Nov; 61(11):2018-23. . View in PubMed
  • The Children’s Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States Cancer. 2014 Oct 01; 120(19):3007-15. . View in PubMed
  • HER-2 expression is not prognostic in osteosarcoma; a Children’s Oncology Group prospective biology study Pediatr Blood Cancer. 2014 Sep; 61(9):1558-64. . View in PubMed
  • Congenital abnormalities and hepatoblastoma: a report from the Children’s Oncology Group (COG) and the Utah Population Database (UPDB) Am J Med Genet A. 2014 Sep; 164A(9):2250-5. . View in PubMed
  • Reply to GMangili et al and C. Lhommé et al. J Clin Oncol. 2014 Sep 01; 32(25):2816-7. . View in PubMed
  • Toward a drug development path that targets metastatic progression in osteosarcoma Clin Cancer Res. 2014 Aug 15; 20(16):4200-9. . View in PubMed
  • Adolescents and young adults with a “rare” cancer: getting past semantics to optimal care for patients with germ cell tumors Oncologist. 2014 Jul; 19(7):689-92. . View in PubMed
  • Response to “High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma” Pediatr Blood Cancer. 2014 May; 61(5):951. . View in PubMed
  • Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children’s oncology group study Pediatr Blood Cancer. 2014 Apr; 61(4):749-52. . View in PubMed
  • Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2014 Mar; 61(3):452-6. . View in PubMed
  • Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children’s Oncology Group J Clin Oncol. 2014 Feb 10; 32(5):465-70. . View in PubMed
  • Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children’s Oncology Group PLoS One. 2014; 9(8):e104378. . View in PubMed
  • High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2013 Dec; 60(12):2042-6. . View in PubMed
  • Outcomes for patients with congenital hepatoblastoma Pediatr Blood Cancer. 2013 Nov; 60(11):1817-25. . View in PubMed
  • Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children’s oncology group (COG) Pediatr Blood Cancer. 2013 Oct; 60(10):1602-5. . View in PubMed
  • Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children’s oncology group Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1837-43. . View in PubMed
  • Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children’s Oncology Group Eur J Cancer. 2013 Jul; 49(10):2384-91. . View in PubMed
  • Children’s Oncology Group’s 2013 blueprint for research: rare tumors Pediatr Blood Cancer. 2013 Jun; 60(6):1016-21. . View in PubMed
  • Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children’s Oncology Group (COG) study Cancer Epidemiol. 2013 Jun; 37(3):318-20. . View in PubMed
  • A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children’s Oncology Group (COG) Phase II study NCT00061893 Pediatr Blood Cancer. 2013 Mar; 60(3):409-14. . View in PubMed
  • Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children’s Oncology Group study Pediatr Blood Cancer. 2013 Feb; 60(2):237-41. . View in PubMed
  • A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group Front Oncol. 2013; 3:57. . View in PubMed
  • Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group J Clin Oncol. 2012 Nov 20; 30(33):4148-54. . View in PubMed
  • “Accelerated ear-age”: a new measure of chemotherapy-induced ototoxicity Pediatr Blood Cancer. 2012 Nov; 59(5):947-9. . View in PubMed
  • Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children’s Oncology Group Cancer. 2012 Sep 15; 118(18):4597-605. . View in PubMed
  • Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children’s oncology group J Clin Oncol. 2012 Jul 10; 30(20):2545-51. . View in PubMed
  • Parental infertility, infertility treatment and hepatoblastoma: a report from the Children’s Oncology Group Hum Reprod. 2012 Jun; 27(6):1649-56. . View in PubMed
  • Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children’s Oncology Group trial (P9962) Pediatr Blood Cancer. 2012 Mar; 58(3):362-5. . View in PubMed
  • A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children’s Oncology Group Eur J Cancer. 2012 Mar; 48(4):579-85. . View in PubMed
  • Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children’s Oncology Group J Clin Oncol. 2012 Jan 20; 30(3):256-62. . View in PubMed
  • Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children’s Oncology Group study Biol Blood Marrow Transplant. 2012 Jan; 18(1):84-91. . View in PubMed
  • Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children’s Oncology Group (COG) study Int J Mol Epidemiol Genet. 2012; 3(4):286-93. . View in PubMed
  • Treatment of hepatoblastoma: the North American cooperative group experience Front Biosci (Elite Ed). 2012 01 01; 4(5):1717-23. . View in PubMed
  • Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children’s Oncology Group Study ASCT0031 Biol Blood Marrow Transplant. 2011 Dec; 17(12):1804-13. . View in PubMed
  • Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2011 Dec 01; 57(6):939-42. . View in PubMed
  • Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children’s Oncology Group Cancer. 2011 Nov 01; 117(21):4966-76. . View in PubMed
  • Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children’s Oncology Group J Clin Oncol. 2011 Aug 20; 29(24):3301-6. . View in PubMed
  • The Children’s Oncology Group routinely applies “lack of efficacy” interim monitoring to its randomized clinical trials Am J Bioeth. 2011 Mar; 11(3):18-9. . View in PubMed
  • Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children’s Oncology Group Clin Cancer Res. 2011 Jan 01; 17(1):56-66. . View in PubMed
  • Infrequent tumor initiative of the Children’s Oncology Group: initial lessons learned and their impact on future plans J Clin Oncol. 2010 Nov 20; 28(33):5011-6. . View in PubMed
  • Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children’s Oncology Groups Study, ASCT0031 Bone Marrow Transplant. 2010 Nov; 45(11):1653-7. . View in PubMed
  • Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children’s Oncology Group study Pediatr Blood Cancer. 2010 Oct; 55(4):629-38. . View in PubMed
  • A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials Contemp Clin Trials. 2010 Sep; 31(5):473-82. . View in PubMed
  • A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children’s Oncology Group study Pediatr Blood Cancer. 2010 Sep; 55(3):440-5. . View in PubMed
  • Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulationa report from the Children’s Oncology Group. Clin Cancer Res. 2010 Aug 01; 16(15):4024-30. . View in PubMed
  • Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children’s Oncology Group J Clin Oncol. 2010 Apr 20; 28(12):1989-94. . View in PubMed
  • Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children’s oncology group Clin Cancer Res. 2010 Jan 15; 16(2):750-4. . View in PubMed
  • Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children’s Oncology Group Cancer. 2009 Dec 15; 115(24):5828-35. . View in PubMed
  • Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2009 Dec; 53(6):1016-22. . View in PubMed
  • Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children’s Oncology Group Cancer. 2009 Nov 15; 115(22):5339-48. . View in PubMed
  • Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children’s Oncology Group study Pediatr Blood Cancer. 2009 Oct; 53(4):590-3. . View in PubMed
  • Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children’s Oncology Group Study J Clin Oncol. 2009 May 20; 27(15):2536-41. . View in PubMed
  • Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children’s oncology group study Cancer. 2009 Apr 15; 115(8):1765-75. . View in PubMed
  • Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma J Bone Joint Surg Am. 2009 Mar 01; 91(3):604-12. . View in PubMed
  • Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children’s Oncology Group Contemp Clin Trials. 2009 Mar; 30(2):123-8. . View in PubMed
  • Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2009 Mar; 52(3):324-7. . View in PubMed
  • Problems identified with phase II stopping rules that employ response and early-progression rates J Clin Oncol. 2009 Feb 01; 27(4):646-7; author reply 647. . View in PubMed
  • International collaboration is feasible in trials for rare conditions: the EURAMOS experience Cancer Treat Res. 2009; 152:339-53. . View in PubMed
  • Phase I study of ch1418 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children’s Oncology Group. J Clin Oncol. 2009 Jan 01; 27(1):85-91. . View in PubMed
  • Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children’s Oncology Group Phase I Consortium Study J Clin Oncol. 2008 Oct 20; 26(30):4921-7. . View in PubMed
  • Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children’s Oncology Group phase I study Neuro Oncol. 2008 Oct; 10(5):752-8. . View in PubMed
  • Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group Semin Oncol. 2008 Oct; 35(5):484-93. . View in PubMed
  • Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children’s Oncology Group Pediatr Blood Cancer. 2008 Sep; 51(3):334-8. . View in PubMed
  • Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children’s Oncology Group Pilot Study J Clin Oncol. 2008 Aug 01; 26(22):3756-62. . View in PubMed
  • Redefining the role of doxorubicin for the treatment of children with hepatoblastoma J Clin Oncol. 2008 May 10; 26(14):2379-83. . View in PubMed
  • A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children’s Oncology Group study Pediatr Blood Cancer. 2008 Apr; 50(4):788-92. . View in PubMed
  • Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children’s Oncology Group Blood. 2008 Mar 15; 111(6):3276-85. . View in PubMed
  • Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children’s Oncology Group report Pediatr Blood Cancer. 2008 Mar; 50(3):533-6. . View in PubMed
  • Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the Children’s Oncology Group J Clin Oncol. 2008 Feb 01; 26(4):633-8. . View in PubMed
  • A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children’s Oncology Group study Pediatr Blood Cancer. 2008 Feb; 50(2):254-8. . View in PubMed
  • Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children’s Oncology Group Study J Clin Oncol. 2008 Jan 20; 26(3):399-405. . View in PubMed
  • Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma J Pediatr Surg. 2007 Dec; 42(12):2050-6. . View in PubMed
  • Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy–a report from the Children’s Oncology Group Pediatr Blood Cancer. 2007 Dec; 49(7):894-900. . View in PubMed
  • Phase II trial of irinotecan in children with refractory solid tumors: a Children’s Oncology Group Study J Clin Oncol. 2007 Oct 10; 25(29):4622-7. . View in PubMed
  • Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children’s Oncology Group Cancer. 2007 Oct 01; 110(7):1542-50. . View in PubMed
  • A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin’s lymphoma: a Children’s Oncology Group study Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5652s-5660s. . View in PubMed
  • Analysis of biologic surrogate markers from a Children’s Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors Pediatr Blood Cancer. 2007 Sep; 49(3):352-7. . View in PubMed
  • Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children’s Oncology Group J Clin Oncol. 2007 May 20; 25(15):2057-62. . View in PubMed
  • Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children’s Oncology Group J Clin Oncol. 2007 Apr 20; 25(12):1505-11. . View in PubMed
  • Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children’s Oncology Group Study J Clin Oncol. 2007 Apr 20; 25(12):1512-8. . View in PubMed
  • Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children’s Cancer Group (CCG) 7943 Cancer. 2007 Apr 15; 109(8):1646-53. . View in PubMed
  • Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease Biol Blood Marrow Transplant. 2007 Apr; 13(4):386-97. . View in PubMed
  • Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children’s Oncology Group Cancer Lett. 2007 Mar 18; 247(2):204-12. . View in PubMed
  • A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children’s Oncology Group study Clin Cancer Res. 2007 Mar 15; 13(6):1789-93. . View in PubMed
  • Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children’s Oncology Group Blood. 2007 Jan 01; 109(1):46-51. . View in PubMed
  • Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children’s Oncology Group study Pediatr Blood Cancer. 2006 Nov; 47(6):790-4. . View in PubMed
  • Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group Cancer Chemother Pharmacol. 2006 Sep; 58(3):343-7. . View in PubMed
  • Local control in pelvic Ewing sarcoma: analysis from INT-0091–a report from the Children’s Oncology Group J Clin Oncol. 2006 Aug 20; 24(24):3838-43. . View in PubMed
  • Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children’s Oncology Group report J Clin Oncol. 2006 Aug 01; 24(22):3678-85. . View in PubMed
  • Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children’s Oncology Group (CCG 09709) J Clin Oncol. 2006 Jul 20; 24(21):3423-30. . View in PubMed
  • Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma J Clin Oncol. 2006 Jun 20; 24(18):2879-84. . View in PubMed
  • Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children’s Oncology Group Cancer. 2006 Apr 15; 106(8):1821-8. . View in PubMed
  • A phase I clinical trial of the hu1418-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children’s Oncology Group. Clin Cancer Res. 2006 Mar 15; 12(6):1750-9. . View in PubMed
  • In utero exposure to female hormones and germ cell tumors in children Cancer. 2006 Mar 01; 106(5):1169-77. . View in PubMed
  • Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children’s Oncology Group Report Pediatr Blood Cancer. 2006 Feb; 46(2):193-7. . View in PubMed
  • Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children’s Oncology Group Clin Cancer Res. 2006 Jan 15; 12(2):516-22. . View in PubMed
  • Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors Int J Hyg Environ Health. 2006 Jan; 209(1):31-40. . View in PubMed
  • Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children’s Oncology Group Study J Clin Oncol. 2005 Dec 20; 23(36):9179-86. . View in PubMed
  • Parental occupational exposure to pesticides and childhood germ-cell tumors Am J Epidemiol. 2005 Nov 01; 162(9):858-67. . View in PubMed
  • A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas Cancer. 2005 Nov 01; 104(9):1968-74. . View in PubMed
  • Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas Cancer. 2005 Sep 15; 104(6):1281-7. . View in PubMed
  • Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children’s Oncology Group Pediatr Blood Cancer. 2005 Sep; 45(3):274-80. . View in PubMed
  • Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children’s Oncology Group Study J Clin Oncol. 2005 Sep 01; 23(25):6172-80. . View in PubMed
  • Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children’s Oncology Group J Clin Oncol. 2005 May 20; 23(15):3376-82. . View in PubMed
  • A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children’s Oncology Group experience Clin Cancer Res. 2005 Apr 01; 11(7):2644-50. . View in PubMed
  • Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children’s Cancer Group (CCG) experience Pediatr Blood Cancer. 2005 Apr; 44(4):338-47. . View in PubMed
  • Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol. 2005 Mar 20; 23(9):2004-11. . View in PubMed
  • Risk of childhood germ cell tumors in association with parental smoking and drinking Cancer. 2005 Mar 01; 103(5):1064-71. . View in PubMed
  • A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumorsA Children’s Oncology Group study. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):672-7. . View in PubMed
  • Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children’s Oncology Group study (ADVL0015) J Clin Oncol. 2004 Dec 01; 22(23):4804-9. . View in PubMed
  • Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children’s Oncology Group phase 1 study Blood. 2004 Nov 01; 104(9):2655-60. . View in PubMed
  • Treatment of metastatic Ewing’s sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide–a Children’s Cancer Group and Pediatric Oncology Group study J Clin Oncol. 2004 Jul 15; 22(14):2873-6. . View in PubMed
  • Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors J Clin Oncol. 2004 Jun 15; 22(12):2445-51. . View in PubMed
  • Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study J Clin Oncol. 2004 Apr 15; 22(8):1413-9. . View in PubMed
  • Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy Ann Surg. 2003 Oct; 238(4):563-7; discussion 567-8. . View in PubMed
  • Fibrolamellar hepatocellular carcinoma in children and adolescents Cancer. 2003 Apr 15; 97(8):2006-12. . View in PubMed
  • Childhood cancer patients’ access to cooperative group cancer programs: a population-based study Cancer. 2003 Mar 01; 97(5):1339-45. . View in PubMed
  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone N Engl J Med. 2003 Feb 20; 348(8):694-701. . View in PubMed
  • Burkitt’s and Burkitt-like lymphoma in children and adolescents: a review of the Children’s Cancer Group experience Br J Haematol. 2003 Feb; 120(4):660-70. . View in PubMed
  • Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples Clin Cancer Res. 2003 Feb; 9(2):837-44. . View in PubMed
  • A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children’s Cancer Group-0952 Neuro Oncol. 2003 01; 5(1):8-13. . View in PubMed
  • Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children’s Cancer Group Leuk Lymphoma. 2002 Oct; 43(10):1945-50. . View in PubMed
  • Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group intergroup study J Clin Oncol. 2002 Jun 15; 20(12):2789-97. . View in PubMed
  • Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report Ann Oncol. 2002 Mar; 13(3):460-9. . View in PubMed
  • Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children’s Cancer Group Study 0942 J Pediatr Hematol Oncol. 2002 Feb; 24(2):89-93. . View in PubMed
  • Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children’s Cancer Group Med Pediatr Oncol. 2001 Nov; 37(5):432-41. . View in PubMed
  • Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma J Immunother. 2001 Nov-Dec; 24(6):511-6. . View in PubMed
  • Phase I study of CI-958 in children and adolescents with recurrent solid tumors Cancer. 2001 Mar 15; 91(6):1166-9. . View in PubMed
  • The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882) J Pediatr Surg. 2001 Jan; 36(1):12-7. . View in PubMed
  • Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch1418) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children’s Cancer Group Study. J Clin Oncol. 2000 Dec 15; 18(24):4077-85. . View in PubMed
  • Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children’s Cancer Group and the Pediatric Oncology Group J Clin Oncol. 2000 Jul; 18(14):2665-75. . View in PubMed
  • A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma Cancer. 2000 Jun 15; 88(12):2838-44. . View in PubMed
  • Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection J Thorac Cardiovasc Surg. 2000 Jun; 119(6):1154-61. . View in PubMed
  • Children’s cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia Cancer J Sci Am. 2000 Feb; 6 Suppl 1:S39-44. . View in PubMed
  • Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children’s Cancer Group Clin Cancer Res. 1999 Dec; 5(12):3956-62. . View in PubMed
  • Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children’s cancer group Am J Obstet Gynecol. 1999 Aug; 181(2):353-8. . View in PubMed
  • Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children’s Cancer Group Intergroup Study J Clin Oncol. 1999 Jul; 17(7):2137-43. . View in PubMed
  • Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences–a Children’s Cancer Group study Genes Chromosomes Cancer. 1999 Jun; 25(2):134-46. . View in PubMed
  • Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children’s Cancer Group trial Clin Cancer Res. 1999 Apr; 5(4):733-7. . View in PubMed
  • Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins J Clin Oncol. 1999 Feb; 17(2):569-77. . View in PubMed
  • A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children’s Cancer Group Cancer. 1998 Oct 01; 83(7):1449-60. . View in PubMed
  • Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children’s Cancer Group J Clin Oncol. 1998 Sep; 16(9):3037-43. . View in PubMed
  • A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors Cancer. 1998 Aug 15; 83(4):813-6. . View in PubMed
  • MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin’s disease in children: results of the Children’s Cancer Group Phase III Trial J Clin Oncol. 1998 Mar; 16(3):897-906. . View in PubMed
  • Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children’s Cancer Group J Clin Oncol. 1998 Mar; 16(3):914-9. . View in PubMed
  • Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children’s Cancer Group Study Clin Cancer Res. 1998 Feb; 4(2):357-60. . View in PubMed
  • Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemiasThe Children’s Cancer Group. Clin Cancer Res. 1998 Jan; 4(1):45-52. . View in PubMed
  • Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children’s Cancer Group J Clin Oncol. 1997 Aug; 15(8):2780-5. . View in PubMed
  • A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children’s Cancer Group Cancer. 1997 Jul 15; 80(2):311-6. . View in PubMed
  • A phase I/IB trial of murine monoclonal anti-GD2 antibody 14G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children’s Cancer Group. Cancer. 1997 Jul 15; 80(2):317-33. . View in PubMed
  • Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children’s Cancer Group trial J Clin Oncol. 1997 Apr; 15(4):1538-43. . View in PubMed
  • Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children’s Cancer Group J Clin Oncol. 1997 Mar; 15(3):1190-7. . View in PubMed
  • Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children’s Cancer Group J Clin Oncol. 1997 Jan; 15(1):76-84. . View in PubMed
  • A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children’s Cancer Group study Invest New Drugs. 1996; 13(4):337-42. . View in PubMed
  • Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin’s lymphoma: a Childrens Cancer Group study J Clin Oncol. 1995 Jun; 13(6):1368-76. . View in PubMed
  • An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States) Cancer Causes Control. 1995 May; 6(3):187-98. . View in PubMed
  • Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin Clin Rheumatol. 1994 Mar; 13(1):60-9. . View in PubMed
  • A phase II study of carboplatin in children with recurrent or progressive solid tumorsA report from the Childrens Cancer Group. Cancer. 1994 Feb 15; 73(4):1297-301. . View in PubMed
  • A phase I study of carboplatin in children with acute leukemia in bone marrow relapseA report from the Childrens Cancer Group. Cancer. 1993 Aug 01; 72(3):917-22. . View in PubMed
  • Patterns of enrollment on cooperative group studiesAn analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 1993 May 15; 71(10 Suppl):3325-30. . View in PubMed
  • Cancer in adolescents and young adults Cancer. 1993 May 15; 71(10 Suppl):3206-9. . View in PubMed
  • Trends in patterns of treatment of childhood cancer in Los Angeles County Cancer. 1993 May 15; 71(10 Suppl):3222-8. . View in PubMed
  • American Cancer Society Workshop on Adolescents and Young Adults with CancerWorkgroup #4: Clinical research implications. Cancer. 1993 Apr 01; 71(7):2423. . View in PubMed
  • Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion Cancer Res. 1993 Mar 01; 53(5):1032-6. . View in PubMed
  • Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhoodReport from the Childrens Cancer Group. Cancer. 1993 Feb 01; 71(3):859-64. . View in PubMed
  • Osteosarcoma in adolescents and young adults: new developments and controversiesThe Childrens Cancer Group (CCG) studies. Cancer Treat Res. 1993; 62:287-91. . View in PubMed
  • Lack of significant activity of 2′-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemiaA randomized phase II trial from the Childrens Cancer Study Group. Am J Clin Oncol. 1992 Dec; 15(6):490-3. . View in PubMed
  • Phase II trial of indicine N-oxide in relapsed acute leukemia of childhoodA report from the Childrens Cancer Study Group. Am J Clin Oncol. 1992 Apr; 15(2):135-40. . View in PubMed
  • The role of surgery in abdominal non-Hodgkin’s lymphoma: experience from the Childrens Cancer Study Group J Pediatr Surg. 1992 Feb; 27(2):230-5. . View in PubMed
  • The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal J Pediatr Surg. 1992 Feb; 27(2):155-63; discussion 163-4. . View in PubMed
  • 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group Med Pediatr Oncol. 1992; 20(4):307-11. . View in PubMed
  • Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group Med Pediatr Oncol. 1992; 20(2):124-9. . View in PubMed
  • Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group J Clin Oncol. 1991 Dec; 9(12):2167-76. . View in PubMed
  • Phase II trial of indicine N-oxide in relapsed pediatric solid tumorsA report from the Childrens Cancer Study Group. Invest New Drugs. 1991 Nov; 9(4):339-42. . View in PubMed
  • Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group J Clin Oncol. 1991 Oct; 9(10):1782-92. . View in PubMed
  • Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children’s Cancer Study Group Cancer Res. 1991 Sep 15; 51(18):4871-5. . View in PubMed
  • The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy J Pediatr Surg. 1991 Sep; 26(9):1074-80; discussion 1080-1. . View in PubMed
  • Systemic treatment of AIDS-related Kaposi’s sarcoma: results of a randomized trial Am J Med. 1991 Apr; 90(4):427-33. . View in PubMed
  • The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urol. 1991 Mar; 145(3):459-64; discussion 464-7. . View in PubMed
  • Carboplatin in childhood brain tumorsA Children’s Cancer Study Group Phase II trial. Cancer. 1990 Dec 15; 66(12):2465-9. . View in PubMed
  • Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin’s disease in children: a report from the Children’s Cancer Study Group J Clin Oncol. 1990 Dec; 8(12):1971-80. . View in PubMed
  • Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients Cancer Res. 1990 Nov 15; 50(22):7226-31. . View in PubMed
  • Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer Semin Urol. 1990 Nov; 8(4):279-84. . View in PubMed
  • Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report Cancer Res. 1990 Oct 15; 50(20):6525-8. . View in PubMed
  • A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group J Neurooncol. 1990 Aug; 9(1):69-76. . View in PubMed
  • The effect of compliance with treatment on survival among patients with hematologic malignancies J Clin Oncol. 1990 Feb; 8(2):356-64. . View in PubMed
  • Germ cell tumors in infancy and childhood: a 45-year experience Pediatr Pathol. 1990; 10(1-2):231-41. . View in PubMed
  • A phase II study of diaziquone in children with recurrent or progressive solid tumorsReport from the Childrens Cancer Study Group. Am J Pediatr Hematol Oncol. 1990; 12(3):301-5. . View in PubMed
  • Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma Cancer. 1989 Sep 01; 64(5):1082-95. . View in PubMed
  • Pulmonary Kaposi’s sarcoma: clinical findings and results of therapy Am J Med. 1989 Jul; 87(1):57-61. . View in PubMed
  • Immature teratomas: identification of patients at risk for malignant recurrence J Natl Cancer Inst. 1989 Jun 07; 81(11):870-4. . View in PubMed
  • The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group J Pediatr Surg. 1988 Feb; 23(2):146-51. . View in PubMed
  • Phase I/II study of bisantrene in childhood cancer: a report from the Childrens Cancer Study Group Med Pediatr Oncol. 1988; 16(5):333-6. . View in PubMed
  • A phase II study of diaziquone in childhood leukemia: a report from the Children’s Cancer Study Group Am J Pediatr Hematol Oncol. 1988; 10(1):18-22. . View in PubMed
  • Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia Cancer Res. 1987 Dec 15; 47(24 Pt 1):6786-92. . View in PubMed
  • AIDS-related malignant lymphoma: results of prospective treatment trials J Clin Oncol. 1987 Sep; 5(9):1322-8. . View in PubMed
  • The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention Br J Cancer. 1987 Jun; 55(6):681-5. . View in PubMed
  • Chronic effects of fractionated renal irradiation on the pharmacokinetics of intravenous methotrexate Int J Radiat Oncol Biol Phys. 1987 May; 13(5):759-64. . View in PubMed
  • Use of unequal allocation in survival trials Stat Med. 1987 Mar; 6(2):119-25. . View in PubMed
  • Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome Cancer. 1987 Feb 15; 59(4):731-8. . View in PubMed
  • Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders Eur J Haematol. 1987 Feb; 38(2):141-7. . View in PubMed
  • A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group Med Pediatr Oncol. 1987; 15(2):69-77. . View in PubMed
  • Fitting models of carcinogenesis to a case-control study of breast cancer J Chronic Dis. 1987; 40 Suppl 2:181S-189S. . View in PubMed
  • Suramin antiviral therapy in the acquired immunodeficiency syndromeClinical, immunological, and virologic results. Ann Intern Med. 1986 Jul; 105(1):32-7. . View in PubMed
  • Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy Cancer. 1986 Jun 01; 57(11):2190-2. . View in PubMed
  • Phase II study of vindesine in the treatment of pediatric patients with solid tumors: a report from the Childrens Cancer Study Group Cancer Treat Rep. 1986 Jun; 70(6):807-9. . View in PubMed
  • Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy J Clin Oncol. 1986 Feb; 4(2):165-9. . View in PubMed
  • Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis Cancer Invest. 1986; 4(5):379-85. . View in PubMed
  • A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome Am J Physiol Imaging. 1986; 1(3):134-41. . View in PubMed
  • Retrovirus and malignant lymphoma in homosexual men JAMA. 1985 Oct 11; 254(14):1921-5. . View in PubMed
  • Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group Cancer Treat Rep. 1985 Oct; 69(10):1211-21. . View in PubMed
  • Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985 Sep 01; 56(5):1206-8.. View in PubMed
  • Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas Diagn Immunol. 1985; 3(3):133-8. . View in PubMed
  • Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study J Clin Oncol. 1984 Jul; 2(7):782-7. . View in PubMed
  • Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women Cancer Res. 1984 Jul; 44(7):3106-8. . View in PubMed
  • Age at natural menopause and breast cancer risk: the effect of errors in recall Am J Epidemiol. 1984 Jan; 119(1):81-5. . View in PubMed
  • Breast cancer and oral contraceptives: reply to critics Lancet. 1983 Dec 17; 2(8364):1414. . View in PubMed
  • Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use Lancet. 1983 Oct 22; 2(8356):926-30. . View in PubMed
  • ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer Nature. 1983 Jun 30; 303(5920):767-70. . View in PubMed
  • Estimation of the distribution of age at natural menopause from prevalence data Am J Epidemiol. 1983 Mar; 117(3):356-61. . View in PubMed

Similar People